Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age34-36
SponsorHackensack Meridian Health

About this trial

Respiratory morbidity presents a significant clinical challenge in the neonatal period, and an individual patient's clinical course is often difficult to predict. This is especially true for late-preterm infants, who share some of the same risks of premature babies in terms or respiratory morbidity, but whose births may not always be attended by a neonatologist, or who may be born at hospitals with lower level Neonatal Intensive Care Units (NICUs) and require transfer if they decompensate.

With this study, the aim is to 1) determine the efficacy of early point of care lung ultrasound (LUS) to predict respiratory decompensation in the first 48 hours of life in late preterm infants and 2) to compare the performance of three lung ultrasound scoring systems, 3 type-of-lung, high risk pattern and total LUS scoring systems.

Eligibility criteria

Qualifiers

Inborn infants born between 34w0d and 36w6d gestational age

In RA or 1 Litre per minute 1LPM NC (room air (RA) or nasal cannula (NC))

Admitted to NICU or Well Baby Nursery (WBN)

Disqualifiers

Patients born <34 weeks or >36w6d

Major genetic anomaly or syndromic condition

Cardiac or pulmonary structural defects

Cord pH <7.0 or 5 minute APGAR 5 or less

Trial design

Treatments tested in this trial

  • Point of care lung ultrasound

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators